Related Experiment Video

Updated: May 11, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Current clinical immunotherapy targets in advanced nonsmall cell lung cancer (NSCLC)

Fiona McCarthy1, Rozita Roshani, Jeremy Steele

  • 11.Barts Cancer Institute, Queen Mary, University of London, Charterhouse Square, London, EC1M 6BQ, UK. t.hagemann@qmul.ac.uk.

Journal of Leukocyte Biology
|May 23, 2013
PubMed

Insights

Non-small cell lung cancer (NSCLC) has a poor prognosis despite new treatments. This review explores immunotherapy, a promising approach for improving survival rates in NSCLC patients.

Area of Science:

  • Oncology
  • Immunology
  • Medical Research

Background:

  • Non-small cell lung cancer (NSCLC) presents significant treatment challenges.
  • Current 5-year survival rates for NSCLC remain below 20%, necessitating novel therapeutic strategies.
  • Recent successes in other cancers highlight the potential of immunotherapy.

Purpose of the Study:

  • To review current immune-modulatory approaches for NSCLC treatment.
  • To provide an overview of the evolving role of immunotherapy in lung cancer care.

Main Methods:

  • Literature review of recent studies and clinical trials.
  • Analysis of immune-modulatory strategies in NSCLC.
  • Synthesis of current research on immunotherapy for lung cancer.

Main Results:

  • Immunotherapy has shown promise in treating various malignancies.
  • There is a growing focus on applying immunotherapy to lung cancer.
  • Current immune-modulatory approaches are being investigated for NSCLC.

Conclusions:

  • Novel therapeutic approaches are crucial for improving NSCLC outcomes.
  • Immunotherapy represents a significant area of focus for future NSCLC treatment.
  • Further research into immune-modulatory strategies may enhance patient survival in NSCLC.
Keywords:
immunotherapeutic agentsmalignanciesprogression-free survivaltumor

More Related Videos

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...